← Open Payments lookup

SHENIKA MAGEE: Open Payments

NPI 1639761547 · MENDENHALL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,791 in 181 payments from 19 companies in 2025. Trend: 2023 $2,389 · 2024 $3,305 · 2025 $4,791

Food & beverage: $4,791
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.31$825
Vanda Pharmaceuticals Inc.24$716
ABBVIE INC.25$450
Alkermes, Inc.13$443
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$432
Otsuka America Pharmaceutical, Inc.10$383
Axsome Therapeutics, Inc.16$332
Janssen Pharmaceuticals, Inc5$237
E.R. Squibb & Sons, L.L.C.5$170
Lundbeck LLC8$167

Products named: INGREZZA, FANAPT, REXULTI, CAPLYTA, Auvelity, VRAYLAR, ARISTADA, LYBALVI.

Industry payments across MS — which companies pay providers there.